- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Psychosis and Dementia in Parkinson’s Disease
Authors
Keywords
Acetylcholine, Antipsychotics, Attention, Cholinesterase inhibitors, Clozapine, Cognitive deficits, Cognitive training, Dementia, Donepezil, Dopamine, Executive function, Hallucinations, Memantine, Memory, Mild cognitive impairment, Neuropsychiatric, Nonmotor symptoms, Nonpharmacological treatments, Parkinson’s disease, Psychosis, Quetiapine, Rivastigmine, Serotonin
Journal
Current Treatment Options in Neurology
Volume 16, Issue 3, Pages -
Publisher
Springer Nature
Online
2014-01-24
DOI
10.1007/s11940-013-0281-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in Executive Function after Acute Bouts of Passive Cycling in Parkinson’s Disease
- (2016) Angela L. Ridgel et al. JOURNAL OF AGING AND PHYSICAL ACTIVITY
- Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson’s disease and Parkinson’s disease psychosis
- (2013) David Hubbard et al. BEHAVIOURAL PHARMACOLOGY
- Pimavanserin for the treatment of Parkinson's disease psychosis
- (2013) Joseph H Friedman EXPERT OPINION ON PHARMACOTHERAPY
- Psychiatric Care in Parkinson’s Disease
- (2013) ROSA QUELHAS Journal of Psychiatric Practice
- Nonpharmacological enhancement of cognitive function in Parkinson's disease: A systematic review
- (2013) John V. Hindle et al. MOVEMENT DISORDERS
- Randomized trial of cognitive speed of processing training in Parkinson disease
- (2013) J. D. Edwards et al. NEUROLOGY
- Efficacy of tailored computer-based neurorehabilitation for improvement of movement initiation in Parkinson's disease
- (2012) E.A. Disbrow et al. BRAIN RESEARCH
- Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study
- (2012) Bruno Dubois et al. MOVEMENT DISORDERS
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis
- (2011) Daniel Weintraub ARCHIVES OF NEUROLOGY
- Feasibility and Acceptance of a Nonpharmacological Cognitive Remediation Intervention for Patients With Parkinson Disease
- (2011) Jan Mohlman et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study
- (2011) Jonathan Bentwich et al. JOURNAL OF NEURAL TRANSMISSION
- Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years
- (2011) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease
- (2011) Anna Prats París et al. MOVEMENT DISORDERS
- The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study
- (2011) Hasmet A. Hanagasi et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease
- (2011) Klaus Seppi et al. MOVEMENT DISORDERS
- MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI
- (2011) Irene Litvan et al. MOVEMENT DISORDERS
- Parkinson's disease: The quintessential neuropsychiatric disorder
- (2011) Daniel Weintraub et al. MOVEMENT DISORDERS
- Cognitive Rehabilitation in Parkinson’s Disease: Evidence from Neuroimaging
- (2011) Cristina Nombela et al. Frontiers in Neurology
- Exercise and Parkinson’s: benefits for cognition and quality of life
- (2010) K. E. Cruise et al. ACTA NEUROLOGICA SCANDINAVICA
- Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy
- (2010) Javier Olazarán et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Rationale for Combined Exercise and Cognition-Focused Interventions to Improve Functional Independence in People with Dementia
- (2010) Jeanette M. Thom et al. GERONTOLOGY
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- (2010) Murat Emre et al. LANCET NEUROLOGY
- Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease
- (2010) Gisela Llebaria et al. MOVEMENT DISORDERS
- The changing face of Parkinson's disease-associated psychosis: A cross-sectional study based on the new NINDS-NIMH criteria
- (2010) Gilles Fénelon et al. MOVEMENT DISORDERS
- Increased 5-HT2Areceptors in the temporal cortex of parkinsonian patients with visual hallucinations
- (2010) Philippe Huot et al. MOVEMENT DISORDERS
- Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- (2010) D. Weintraub et al. NEUROLOGY
- Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis
- (2010) D. Aarsland et al. NEUROLOGY
- A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease
- (2010) Paul Shotbolt Neuropsychiatric Disease and Treatment
- QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY
- (2009) HUBERT H. FERNANDEZ et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson’s disease
- (2009) Silvie Sedláčková et al. JOURNAL OF NEURAL TRANSMISSION
- Epidemiology of psychosis in Parkinson's disease
- (2009) Gilles Fénelon et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
- (2009) Dag Aarsland et al. LANCET NEUROLOGY
- Randomized controlled trial of memantine in dementia associated with Parkinson's disease
- (2009) Iracema Leroi et al. MOVEMENT DISORDERS
- Neuropsychiatric symptoms in Parkinson's disease
- (2009) Dag Aarsland et al. MOVEMENT DISORDERS
- The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease
- (2009) Paolo Barone et al. MOVEMENT DISORDERS
- Hallucinations in Parkinson disease
- (2009) Nico J. Diederich et al. Nature Reviews Neurology
- The progression of pathology in longitudinally followed patients with Parkinson’s disease
- (2008) Glenda Halliday et al. ACTA NEUROPATHOLOGICA
- Benefits of physical exercise on executive functions in older people with Parkinson’s disease
- (2008) Kátia Tanaka et al. BRAIN AND COGNITION
- A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease
- (2008) J Grace et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Executive functions are impaired in patients with Parkinson's disease with visual hallucinations
- (2008) J Barnes et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- The effectiveness of exercise interventions for people with Parkinson's disease: A systematic review and meta-analysis
- (2008) Victoria A. Goodwin et al. MOVEMENT DISORDERS
- Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
- (2008) Laura Marsh et al. MOVEMENT DISORDERS
- Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
- (2008) D. Aarsland et al. NEUROLOGY
- A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia
- (2007) Javier Pagonabarraga et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started